Could anti-obesity medications affect survival in people with knee or hip osteoarthritis?
New research published in Arthritis & Rheumatology suggests that for people overweight or with obesity who also have knee or hip osteoarthritis, a slow-to-moderate—but not fast—rate of weight loss caused by anti-obesity medications may lower their risk of premature death. Among 6,524 participants with knee or hip osteoarthritis who were taking orlistat, sibutramine, or rimonabant,…